GALMED PHARMACEUTICALS LTD. GLMD Balance Sheet

Jun'18	Dec'17	Jun'17	Dec'16	Jun'16	Dec'15	Dec'14	Dec'13
Assets
Current assets
Cash and cash equivalents
6,151	13,021	1,747	3,097	2,946	4,156	23,736	137
Short-term deposit
-	-	-	-	-	-	6,000	0
Marketable securities
87,954	5,976	7,408	12,351	13,736	18,845	2,250	0
Other accounts receivable
368	155	266	284	479	379	165	16
Total current assets
94,473	19,152	9,421	15,732	17,161	23,380	32,151	153
Property and equipment, net
374	491	606	718	840	883	774	13
Total assets
94,847	19,643	10,027	16,450	18,001	24,263	32,925	166
Liabilities and stockholders' equity
Current liabilities
Trade payables
2,346	2,276	2,365	3,122	2,965	2,259	875	1,355
Other accounts payable
1,458	1,034	185	363	388	282	243	334
Short-term portion of deferred revenue
0	538	1,085	1,094	-	-	-	-
Total current liabilities
3,804	3,848	3,635	4,579	3,353	2,541	1,118	1,689
Related parties
-	-	150	267	222	177	400	428
Deferred revenue
-	-	0	529	-	-	-	-
Total long-term liabilities
-	-	150	796	222	177	400	428
Stockholders' equity:
Ordinary shares par value NIS 0.01 per share; Authorized 50,000,000; Issued and outstanding: 20,912,754 shares as of June 30, 2018; 14,435,161 shares as of December 31, 2017
58	40	34	34	32	32	32	10
Additional paid-in capital
172,824	92,381	76,402	75,446	70,160	69,086	68,116	25,681
Accumulated other comprehensive loss
-29	-7	-20	-85	-104	-206	4	0
Accumulated deficit
-81,810	-76,619	-70,174	-64,320	-55,662	-47,367	-36,745	-27,642
Total stockholders' equity
91,043	15,795	6,242	11,075	14,426	21,545	31,407	-1,951
Total liabilities and stockholders' equity
94,847	19,643	10,027	16,450	18,001	24,263	32,925	166